Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Johannes Rudolph to Binding Sites

This is a "connection" page, showing publications Johannes Rudolph has written about Binding Sites.

 
Connection Strength
 
 
 
0.464
 
  1. Rudolph J, Roberts G, Luger K. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs. Nat Commun. 2021 02 02; 12(1):736.
    View in: PubMed
    Score: 0.145
  2. Rudolph J, Mahadevan J, Luger K. Probing the Conformational Changes Associated with DNA Binding to PARP1. Biochemistry. 2020 06 02; 59(21):2003-2011.
    View in: PubMed
    Score: 0.138
  3. Rudolph J, Xiao Y, Pardi A, Ahn NG. Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors. Biochemistry. 2015 Jan 13; 54(1):22-31.
    View in: PubMed
    Score: 0.095
  4. Sohn J, Rudolph J. The energetic network of hotspot residues between Cdc25B phosphatase and its protein substrate. J Mol Biol. 2006 Oct 06; 362(5):1060-71.
    View in: PubMed
    Score: 0.053
  5. Pegram LM, Liddle JC, Xiao Y, Hoh M, Rudolph J, Iverson DB, Vigers GP, Smith D, Zhang H, Wang W, Moffat JG, Ahn NG. Activation loop dynamics are controlled by conformation-selective inhibitors of ERK2. Proc Natl Acad Sci U S A. 2019 07 30; 116(31):15463-15468.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)